These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33845354)

  • 21. Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes.
    Chiu KP; Ariyaratne P; Xu H; Tan A; Ng P; Liu ET; Ruan Y; Wei CL; Sung WK
    BMC Cancer; 2007 Jun; 7():109. PubMed ID: 17594473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
    Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
    Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tracking of Melanoma Cell Plasticity by Transcriptional Reporters.
    Vidal A; Redmer T
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
    Pandian V; Ramraj S; Khan FH; Azim T; Aravindan N
    Stem Cell Res Ther; 2015 Feb; 6(1):2. PubMed ID: 25888913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.
    Sinnberg T; Levesque MP; Krochmann J; Cheng PF; Ikenberg K; Meraz-Torres F; Niessner H; Garbe C; Busch C
    Mol Cancer; 2018 Feb; 17(1):59. PubMed ID: 29454361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
    Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
    Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.
    Hoek K; Rimm DL; Williams KR; Zhao H; Ariyan S; Lin A; Kluger HM; Berger AJ; Cheng E; Trombetta ES; Wu T; Niinobe M; Yoshikawa K; Hannigan GE; Halaban R
    Cancer Res; 2004 Aug; 64(15):5270-82. PubMed ID: 15289333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
    Shi L; Huo JW; Chen SS; Xue JX; Gao WY; Li XY; Song YH; Xu HT; Zhu XW; Chen K
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5332-5342. PubMed ID: 31298385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microenvironment-derived factors driving metastatic plasticity in melanoma.
    Kim IS; Heilmann S; Kansler ER; Zhang Y; Zimmer M; Ratnakumar K; Bowman RL; Simon-Vermot T; Fennell M; Garippa R; Lu L; Lee W; Hollmann T; Xavier JB; White RM
    Nat Commun; 2017 Feb; 8():14343. PubMed ID: 28181494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines.
    Kovacs D; Migliano E; Muscardin L; Silipo V; Catricalà C; Picardo M; Bellei B
    Oncotarget; 2016 Jul; 7(28):43295-43314. PubMed ID: 27175588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells.
    Schlegel NC; von Planta A; Widmer DS; Dummer R; Christofori G
    Exp Dermatol; 2015 Jan; 24(1):22-8. PubMed ID: 25363503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.
    Gerber T; Willscher E; Loeffler-Wirth H; Hopp L; Schadendorf D; Schartl M; Anderegg U; Camp G; Treutlein B; Binder H; Kunz M
    Oncotarget; 2017 Jan; 8(1):846-862. PubMed ID: 27903987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
    Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
    Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic potential of alternative transcript isoforms across human tumors.
    Trincado JL; Sebestyén E; Pagés A; Eyras E
    Genome Med; 2016 Aug; 8(1):85. PubMed ID: 27535130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying mRNA, microRNA and protein profiles of melanoma exosomes.
    Xiao D; Ohlendorf J; Chen Y; Taylor DD; Rai SN; Waigel S; Zacharias W; Hao H; McMasters KM
    PLoS One; 2012; 7(10):e46874. PubMed ID: 23056502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole transcriptome RNA-seq analysis: tumorigenesis and metastasis of melanoma.
    Zhao H; Li Y; Wang S; Yang Y; Wang J; Ruan X; Yang Y; Cai K; Zhang B; Cui P; Yan J; Zhao Y; Wakeland EK; Li Q; Hu S; Fang X
    Gene; 2014 Sep; 548(2):234-43. PubMed ID: 25034661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans-differentiation, and drug resistance.
    Castro-Pérez E; Singh M; Sadangi S; Mela-Sánchez C; Setaluri V
    Pigment Cell Melanoma Res; 2023 Sep; 36(5):330-347. PubMed ID: 37132530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity.
    Yao J; Caballero OL; Huang Y; Lin C; Rimoldi D; Behren A; Cebon JS; Hung MC; Weinstein JN; Strausberg RL; Zhao Q
    Cancer Immunol Res; 2016 Jun; 4(6):552-61. PubMed ID: 27045022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.